HIV Type-O Envelope

Products_type

Recombinant Protein
Products_short_name

[HIV Type-O Envelope]
Products_name_syn

[HIV Type-O Envelope; HIV Type-O Envelope; HIV Type-O Envelope]
Specificity

Immunoreactive with all sera of HIV type-O infected individuals.
Purity

Greater than 95.0% as determined by HPLC analysis and SDS-PAGE.
Form

1 mg/ml in water.Sterile filtered colorless clear solution.
Gene

The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome(AIDS). AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Without treatment, average survival time after infection with HIV is estimated to be 9 to 11 years, depending on the HIV subtype. Infection with HIV occurs by the transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells. recombinant HIV 1 and 2 gag gene proteins p24, p17, p55 immunodominant epitopes and envelope glycoproteins, gp120 are used for production of diagnostic detection antibodies.

Identity

HGNC:4921
Gene

HIVEP2
Long gene name

HIVEP zinc finger 2
Synonyms gene name
- human immunodeficiency virus type I enhancer-binding protein 2
- human immunodeficiency virus type I enhancer binding protein 2
Synonyms
- MBP-2
- HIV-EP2
- MIBP1
- ZAS2
- Schnurri-2
- ZNF40B
Synonyms name
- c-myc intron binding protein 1
GenBank acession
- M60119
Locus

6q24.2
Discovery year

1992-10-21
Entrez gene record

3097
Pubmed identfication
- 1733857
- 2022670
Classification
- Zinc fingers C2H2-type
VEGA ID

OTTHUMG00000015713